Who owns the ODEYVEAN trademark?

The ODEYVEAN trademark is owned by Tanabe Pharma Corporation.

What class is the ODEYVEAN trademark registered in?

The ODEYVEAN trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for ODEYVEAN?

The USPTO serial number for ODEYVEAN is 79311528.

What is the registration number for ODEYVEAN?

ODEYVEAN is registered under USPTO registration number 6604611.

Sealvo

Home Search: ODEYVEANODEYVEAN #79311528

Back

Updated Oct 6, 2026·42 searches this week

View on USPTO TSDR Find similar marks

ODE

USPTO Trademark Record

REGISTERED

ODEYVEAN

SN 79311528·Reg 6604611·Filed Apr 05, 2021

Owner Tanabe Pharma Corporation

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

ODEYVEAN (Serial No. 79311528), Registration No. 6604611, is a registered US trademark filed on Apr 05, 2021 by Tanabe Pharma Corporation. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: January 04, 2028

Mark Intelligence

ODEYVEAN (Reg. #6604611) is a registered US trademark that has been protecting its owner, Tanabe Pharma Corporation, since 2021. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Apr 05, 2021

SERIAL

79311528

REG#

6604611

REGISTERED

Jan 04, 2022

Filing Information

StatusREGISTERED

Filing DateApr 05, 2021

Serial Number79311528

Registration No.6604611

Registration DateJan 04, 2022

Status DateJan 04, 2022

Published for OppositionOct 19, 2021

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

23 events

CHANGE OF NAME/ADDRESS REC'D FROM IB

Apr 23, 2026

CHANGE OF NAME/ADDRESS REC'D FROM IB

FINAL DECISION TRANSACTION PROCESSED BY IB

Jul 12, 2022

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Jun 23, 2022

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Jun 23, 2022

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Apr 04, 2022

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Jan 04, 2022

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

Oct 19, 2021

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Oct 19, 2021

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 29, 2021

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

Sep 14, 2021

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO LIE

Sep 14, 2021

ASSIGNED TO LIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 25, 2021

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 25, 2021

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 25, 2021

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Jun 21, 2021

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Jun 01, 2021

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Jun 01, 2021

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

May 29, 2021

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

May 28, 2021

NON-FINAL ACTION WRITTEN

APPLICATION FILING RECEIPT MAILED

May 26, 2021

APPLICATION FILING RECEIPT MAILED

ASSIGNED TO EXAMINER

May 25, 2021

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

May 22, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

May 20, 2021

SN ASSIGNED FOR SECT 66A APPL FROM IB

Other Marks by Tanabe Pharma Corporation

Additional USPTO filings from the same owner.

TAN

TANABE PHARMA

79428704

Tanabe Pharma Corporation

REGISTERED

LOG

LogoMark

79167319

Tanabe Pharma Corporation

REGISTERED

LIG

LIGHTMARE

79431966

Tanabe Pharma Corporation

REGISTERED

ENG

ENGOLCE

98041497

TANABE PHARMA CORPORATION

REGISTERED

ODEYVEAN

Run a conflict check

Other Marks by Tanabe Pharma Corporation

Get pre-filing clearance

Search 14M+ trademarks

Resources

Company